Envision Healthcare Corporation (NYSE:EVHC) Releases FY17 Earnings Guidance
Envision Healthcare Corporation (NYSE:EVHC) updated its FY17 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $3.35-3.45 for the period, compared to the Thomson Reuters consensus estimate of $3.45. The company issued revenue guidance of $7.75-8.0 billion, compared to the consensus revenue estimate of $7.96 billion.Envision Healthcare Corporation also updated its Q3 guidance to $0.87-0.83 EPS.
Several research firms recently issued reports on EVHC. Cantor Fitzgerald reissued a buy rating on shares of Envision Healthcare Corporation in a research report on Monday, July 24th. Royal Bank Of Canada increased their target price on Envision Healthcare Corporation from $72.00 to $77.00 and gave the stock an outperform rating in a research report on Tuesday, June 27th. Zacks Investment Research raised Envision Healthcare Corporation from a strong sell rating to a buy rating and set a $70.00 target price on the stock in a research report on Tuesday, July 4th. Canaccord Genuity reaffirmed a buy rating and issued a $86.00 target price on shares of Envision Healthcare Corporation in a research report on Tuesday, April 18th. Finally, BidaskClub raised Envision Healthcare Corporation from a sell rating to a hold rating in a research report on Saturday, June 17th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of Buy and an average target price of $71.89.
Envision Healthcare Corporation (NYSE:EVHC) traded down 1.33% on Monday, hitting $55.05. The stock had a trading volume of 2,272,795 shares. The firm’s market cap is $6.39 billion. Envision Healthcare Corporation has a 1-year low of $53.12 and a 1-year high of $74.75. The firm’s 50-day moving average price is $60.18 and its 200-day moving average price is $61.73.
In other news, insider Robert Jon Coward sold 1,500 shares of the business’s stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $62.69, for a total transaction of $94,035.00. Following the completion of the sale, the insider now owns 97,863 shares in the company, valued at $6,135,031.47. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 3.10% of the company’s stock.
About Envision Healthcare Corporation
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.